iBio, Inc. (IBIO): Shareholders' Equity
$85.71M
As of 2026-06-30
+77.3%
3-year compound annual growth
-4.6%
5-year compound annual growth
+24.0%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $85.71M | +476.0% | 2026-08-28, Balance as of period end |
| 2025-06-30 | $14.88M | -30.2% | 2026-08-28, Balance as of period end |
| 2024-06-30 | $21.32M | +38.6% | 2025-09-05, Balance as of period end |
| 2023-06-30 | $15.38M | -75.8% | 2024-09-24, Balance as of period end |
| 2022-06-30 | $63.48M | -41.5% | 2023-09-27, Balance as of period end |
| 2021-06-30 | $108.58M | +91.8% | 2022-10-11, Balance as of period end |
| 2020-06-30 | $56.62M | n/m | 2021-09-28, Balance as of period end |
| 2019-06-30 | $2.46M | -84.8% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $16.17M | +81.4% | 2019-08-26, Balance as of period end |
| 2017-06-30 | $8.91M | -10.3% | 2018-09-18, Balance as of period end |
| 2016-06-30 | $9.94M | -11.5% | 2017-09-15, Balance as of period end |
| 2015-06-30 | $11.23M | +84.1% | 2016-10-13, Balance as of period end |
| 2014-06-30 | $6.10M | +20.3% | 2015-10-13, Balance as of period end |
| 2013-06-30 | $5.07M | -17.8% | 2014-09-29, Balance as of period end |
| 2012-06-30 | $6.17M | n/m | 2013-10-04, Balance as of period end |
| 2011-06-30 | $196.6K | n/a | 2012-10-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$37.0K | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $41.98M | -54.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗